Last reviewed · How we verify

NCT06407414

Effectiveness of Neuromuscular Exercise in Patellofemoral Pain Syndrome

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing control in Patellofemoral Pain Syndrome in 50 participants. Completed in 11 September 2024.

Timeline
14 May 2024
Primary endpoint
11 September 2024
11 September 2024

Quick facts

Lead sponsorUskudar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date14 May 2024
Primary completion11 September 2024
Estimated completion11 September 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar University

Who can join

Adults 30 to 60, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the effects of a neuromuscular exercise program on strength, balance, sleep quality and functionality in individuals with Patellofemoral pain syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of control

Trials testing the same drug.

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

Other Uskudar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06407414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing